Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 1,001–1,020 of 1,020
Scheuermeyer, F. X., Mackay, M., Christenson, J., Grafstein, E., Pourvali, R., Heslop, C., MacPhee, J., Ward, J., Heilbron, B., McGrath, L., et al. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12750 · Cited by 48
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Self-citationReps, J. M., Williams, R. D., You, S. C., Falconer, T., Minty, E., Callahan, A., Ryan, P. B., Park, R. W., Lim, H.-S., & Rijnbeek, P. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-00991-3 · Cited by 40
“To demonstrate this we selected the prediction problem of 1-year risk of stroke in newly diagnosed atrial fibrillation patients as there are multiple existing models that are used clinically, namely Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) (no prior stroke model) [8], Framingham (no prior stroke…”
MethodKirchhof, P., Schmalowsky, J., Pittrow, D., Rosin, L., Kirch, W., Wegscheider, K., Meinertz, T., & for the ATRIUM Study Group (2014) · Clinical Cardiology · doi:10.1002/clc.22272 · Cited by 37
Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., Sommer, P., Richter, S., Rolf, S., Husser, D., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.039 · Cited by 36
TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis
Polvinen, E., Matilainen, M., Nylund, M., Sucksdorff, M., & Airas, L. M. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200133 · Cited by 36
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes
Abegaz, T. M., Baljoon, A., Kilanko, O., Sherbeny, F., & Ali, A. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107289 · Cited by 34
Latest hypertension research to inform clinical practice in Asia
Kario, K., Mogi, M., & Hoshide, S. (2022) · Hypertension Research · doi:10.1038/s41440-022-00874-8 · Cited by 32
“the risk of stroke and systemic emboli, but the risk is even greater in presence of both AF and hypertension [48, 49].”
BackgroundZubaid, M., Rashed, W. A., Alsheikh-Ali, A. A., Al-Zakwani, I., AlMahmeed, W., Shehab, A., Sulaiman, K., Qudaimi, A. A., Asaad, N., & Amin, H. (2015) · Angiology · doi:10.1177/0003319714536980 · Cited by 29
How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
Shoemaker, M. B., Shah, R. L., Roden, D. M., & Perez, M. V. (2020) · Circulation Research · doi:10.1161/circresaha.120.316365 · Cited by 27
Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015) · Chest · doi:10.1378/chest.14-2096 · Cited by 26
Self-citationSupersparse Linear Integer Models for Interpretable Classification
Ustun, B., Tracà, S., & Rudin, C. (2013) · arXiv · doi:10.48550/arxiv.1306.6677 · Cited by 26
Fauchier, L., Boriani, G., de Groot, J. R., Kreutz, R., Rossing, P., & Camm, A. J. (2021) · EP Europace · doi:10.1093/europace/euab184 · Cited by 22
Evaluation of recipients with significant comorbidity - patients with cardiovascular disease
Tsochatzis, E. A., Watt, K. D., VanWagner, L. B., Verna, E. C., & Berzigotti, A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.023 · Cited by 22
Are there gender differences in outcomes after the Cox-Maze procedure for atrial fibrillation?
Henry, L., Hunt, S., Holmes, S. D., Martin, L. M., & Ad, N. (2013) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1097/imi.0b013e3182a2306c · Cited by 17
“Despite women being sicker and having a higher risk for complications, the Cox-Maze procedure was found to be equally safe and effective for women and seems to significantly reduce the risk for stroke through the return of sinus rhythm and the disarticulation of the left atrial appendage.(36,37) Recent findings for th…”
BackgroundAbdulrahman, A., & Richards, D. (2021) · Multimodal Technologies and Interaction · doi:10.3390/mti5090056 · Cited by 11
Olsson, L. G., Swedberg, K., Lappas, G., Stewart, S., & Rosengren, A. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.028 · Cited by 10
“Moreover, many of the important comorbidities have shown prognostic improvements during this time-period [16–18,23].”
BackgroundHaemers, P., Claus, P., & Willems, R. (2012) · Cardiology Research and Practice · doi:10.1155/2012/658937 · Cited by 7
Editorial commentary: the CHA2DS2VASc score and its black and white items
Fauchier, L., Bodin, A., & Bisson, A. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.11.012 · Cited by 3
Raj (2024) · doi:10.1111/imj.16044 · Cited by 2
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.